Osteoporosis is common in patients with rheumatoid arthritis even without corticosteroid therapy. Radiological studies have shown that osteoporosis is generalised, occurring to the same degree in all parts of the peripheral skeleton (Kennedy and Lindsay, 1977) . Rarely, osteomalacia may be found in patients with rheumatoid arthritis, usually in elderly patients confined to home (Maddison and Bacon, 1974) . However, most physicians would probably not consider that there was a general metabolic bone disorder underlying osteoporosis in rheumatoid arthritis. We were therefore surprised to find an unexpectedly high prevalence of hypercalcaemia in patients with the disease (Kennedy et al., 1975) , and this paper describes further studies on the pathogenesis of this hypercalcaemia.
Material and methods

PATIENTS STUDIED
Twenty-three of 50 randomly selected female patients suffering from 'definite' or 'classical' rheumatoid arthritis, as defined by the diagnostic criteria of the American Rheumatism Association (Ropes et al., 1959) were found to be hypercalcaemic, that is, serum calcium concentration greater than 2.60 mmol/l when the total serum calcium concentration was corrected for the corresponding albumin concentration as outlined below. All these 23 patients were ambulant and all participated in the study with full knowledge of its content. All blood samples (years) mm/l h 402 Kennedy, Allam, Rooney, Watson, Fairney, Buchanan, Hillyard were obtained without haemostasis between 8.30 and 9.30 a.m., the patients having fasted and taken no medication since 6 p.m. the evening before. Prior to the study all patients were taking medication: 1 patient was receiving digoxin and a diuretic, 1 was on phenobarbitone for epileptic seizures, 3 were receiving low-dose corticosteroid therapy, that is, less than 10 mg prednisolone per day, and the remainder were receiving a variety of non-steroidal anti-inflammatory analgesics. The clinical and laboratory data of the 23 patients arc summarised in ' Table 1 .
DESIGN OF CORRECTION OF S.ERUM CALCIUM CONCENTRATION FOR HYPOALB UMINAEMIA
The serum calcium levels were corrected for albumin employing a formula derived in the following way. A regression analysis ofcalcium on albumin was carried out on the results from 150 normal healthy persons, half of whom were female. Their age ranges were as follows: 17 to 69 years for females, and 18 to 70 years for males. A regression equation was then calculated on the total 150 subjects. It is of interest that when the serum albumin concentration was zero the regression line cut the Y axis at 1 .43 mmol/l, which represents the ultrafiltrable calcium concentration, and corresponds to that found by Robertson (1969) (1.40 mmol/l); Pedersen (1970) ( This indicates that calcium concentration changes by 0.0194 mmol/l for every 1 g/l change in albumin and that therefore for every 1 g/l by which the plasma albumin exceeds the normal mean of 47 * 0 g/l 0.0194 is subtracted from the total plasma calcium and a corresponding addition is made when plasma albumin is less than 47-0 g/l.
In addition, a biochemical mineral metabolism screen was carried out on each subject. This involved utilising data from blood and urine to calculate certain derived values: (1) fasting urinary calcium/ creatinine ratio; (2) urinary calcium excretion (CaE) per litre glomerular filtrate (Nordin et al., 1967) ; (3) theoretical maximum tubular reabsorption capacity (Tm) for calcium, TmCa (Nordin et al., 1976) ; (4) the most reliable indices of renal handling of phosphate (Peterson, 1973) , i.e., TmPO4 GFR (theoretical tubular maximum reabsorption of phosphate corrected for glomerular function (Bijvoet, 1969; Bijvoet et al., 1969) and IPE (index of phosphate excretion) (Nordin and Bulusu, 1968) .
The derivation and rationale of employing the CaE per litre GF and the TmCa are well described by Marshall (1976) and by Nordin, Horsman and Aaron (1976) . The calculation of these indices was carried out in the MRC Mineral Metabolism Unit at Leeds Royal Infirmary, and we are grateful for the co-operation extended by Professor B. E. C. Nordin and colleagues.
MEASUREMENT OF SERUM IONISED CALCIUM
A 10 ml clotted sample of blood, from which air was excluded immediately after withdrawal, was used for the estimations of ionised calcium. Serum ionised calcium concentration was measured with a flow-through electrode system in which the electrodes were maintained at 370C in a thermostatically controlled cabinet. At each measurement run the electrode was calibrated for direct sodium interference as well as for its response to standard calcium solutions, since the effect of sodium on the electrode has been found to vary (Watson, 1975) . Immediately after each measurement of ionised calcium the pH of the same serum sample was measured at 370C with a glass capillary electrode system (EIL Model SHH 33).
Corrections were applied to the observed ionised calcium results to take account of direct sodium interference, and for this purpose a linear relationship was assumed between log (Cal+) and sodium concentration (Watson, 1975 (Pedersen, 1972) and from the results of observations of the influence of pH on serum ionised calcium with varying albumin and calcium concentrations (Watson, 1975) . The reproducibility of this method has been shown to be highly satisfactory, with a coefficient of variation of 0-760% (Watson, 1975 (Berson et al., 1963) . Calcitonin assays were performed by the latter (Coombes et al., 1974) . Estimation of serum 25-hydroxy-vitamin D was performed by the method of Haddad and Chyu (1971) using vitamin-D-replete rat kidney cytosol protein (McLaughlin et al., 1974) . Other assays included serum immunoreactive gastrin (Buchanan and McCarrol, 1971) , serum immunoreactive pancreatic glucagon (Buchanan, 1973; Flanagan et al., 1974) , urinary D-glucaric acid excretion (Simmons et al., 1974) , and urinary hydroxyproline (Goverde and Veenkamp, 1972) . In all assays reference data were obtained from estimations performed on fasting subjects matched for age and sex.
RADIOLOGICAL ASSESSMENT Radiological films of the hands and wrists were assessed for joint space narrowing and erosions by the method described by Sharp et al. (1971) . The metacarpal index of Barnett and Nordin (1960) (Marshall, 1976) .
When the serum ionised calcium, serum phosphate and alkaline phosphatase are grouped according to Table 4 that the mean serum alkaline phosphatase lies above the upper limit of the reference range. Indeed, 10 of the 23 patients had raised serum alkaline phosphatase levels, whereas there was no patient who showed increases of serum bilirubin, aspartate (Nordin et al., 1976) the results for urinary calcium and urinary hydroxyproline levels were correlated in the patients studied (Fig. 3) . It can be seen that there is a statistically significant positive correlation (r=0.54, P<0 005) between these indices. The results of the immunoreactive parathormone assay (Fairney et al., 1973 ) and other hormone assays are shown in Table 5 . It can be seen that no patient had an elevated parathormone level, and indeed in 16 the level was below the lower limit of the normal range. In the other assay (Berson et al., 1963) all levels lay within the normal range. Only one patient (patient 11) had an raised serum immunoreactive gastrin level: this patient also had raised serum calcitonin and ionised calcium levels, a low parathyroid hormone (PTH) level, and the highest serum alkaline phosphatase. The patient with the low 25-OH vitamin D level (patient 23) had a markedly raised urinary D-glucaric acid concentration. This patient had been receiving phenobarbitone for epilepsy. Serum magnesium concentrations (0 80 ± 0-06 mmol/l) were within normal limits. Patients with an elevated serum ionised calcium level tended to have lower serum phosphate levels and TmP/GFR and higher TmCa/GFR ( Robertson and Peacock (1968) and Ladenson and Bowers (1973) both obtained higher mean values, 1 -23 and 1 .28 mmol/l respectively, but Ryden et al., (1976) obtained a mean value of 1-03 mmol/l, which was lower than that obtained in the control subjects in the present study. It should be noted that Ladenson and Bowers (1973) carried out their estimations at a temperature of 250C, which would tend to increase the serum ionised calcium result. Ryden and her colleagues (1976) do not, unfortunately, state the temperature at which they carried out their estimations. Varghese (1973) , using spectrophotometry, obtained a mean value slightly lower (1 -04 mmol/l) than that obtained in the present study. His subjects were also fasting and the working temperature was 370C. The reproducibility of the method employed in the present study was high, with a coefficient of variation of 0.76% in 20 samples from the same bulk source (Watson, 1975) . Thus it seems reasonable to conclude that the 8 patients with rheumatoid arthritis had definite, though in some patients slight, elevations in serum ionised calcium levels.
Further confirmation of the finding of raised serum ionised calcium levels in rheumatoid arthritis has been obtained in a study of 52 patients with the disease studied in South Africa. Approximately one-third (17) of the patients had raised serum ionised calcium levels when compared to a healthy control group matched for age and sex (Meyers et al., 1976) . This method employed an Orion calcium ion exchange electrode model SS-20 and the temperature at which estimations were performed was 370C. The correction factor employed in the present study is also central to the investigation, and its validation is therefore crucial. As previously indicated, the regression line of serum calcium concentration on serum albumin level when extended to the Y axis when the albumin concentration is zero intersects at 1 .43 mmol/l, which corresponds to the serum ultrafilterable calcium concentration found by others (Robertson, 1969; Pedersen, 1970; Rose, 1972; Payne et al., 1973 The serum ionised calcium is the physiologically active fraction of total serum calcium, and consequently, when raised, it is of clinical significance.
The associated biochemical results of the mineral metabolism screen are therefore of interest. The finding of hypophosphataemia, increased serum alkaline phosphatase, hyperchloraemia, reduced tubular reabsorption of phosphate, and increased tubular reabsorption of calcium suggest possible parathyroid overactivity. The elevation of serum alkaline phosphatase in patients with rheumatoid arthritis may be ofeither bone (Maddison and Bacon, 1974) or liver origin (Webb et al., 1975) . Unfortunately, isoenzyme studies were not available to determine the source of the increased serum alkaline phosphatase levels in the present study. However, none of the patients had clinical evidence of liver disease, and all had normal serum levels of bilirubin and the enzymes AST and ALT. It is of interest that of 6 patients with elevated hydroxyproline/creatinine ratios 4 had elevated serum alkaline phosphatase levels. However, 6 patients with elevated serum alkaline phosphatase levels had normal hydroxyproline/creatinine ratios. Increased hydroxyproline excretion in the urine reflects an increased turnover of collagen, and has been reported by some (Hartmann et al., 1969) but not all workers (Ziff et al., 1956) in patients with rheumatoid arthritis. The significant correlation between the increased urinary calcium and hydroxyproline results (Fig. 3) suggests that the underlying cause for this is likely to be increased bone turnover.
The question arises whether this evidence suggesting increased bone turnover and the other biochemical abnormalities noted might be interpreted as indicating hyperparathyroid activity. It is therefore of interest that patients who had raised serum ionised calcium level tended to have lower serum phosphate levels and TmP/GFR and higher TmCa/ GFR. Thus, one can only tentatively conclude that there is some evidence of increased bone turnover and possible parathyroid overactivity. In this context the results of the hormone assays were of particular interest.
The most accurate test for parathyroid overactivity is regarded as the direct measurement of serum PTH. By both methods of immunoassay employed in this study the serum levels of PTH were normal or reduced. Serum calcitonin levels were elevated in two patients only, and it is of interest that 1 of those had the highest serum ionised calcium concentration (patient 11, Table 5 ). The cause of the elevated calcitonin level may be a response to the elevation of serum ionised calcium as has been shown in some mammalian species (Gray and Munson, 1969) , but not yet in man (Schneider and Sherwood, 1974) .
Hypercalcaemia and hyperparathyroidism may be associated with hypergastrinaemia (Turbey and Passaro, 1972; Barreras, 1973) , and rheumatoid arthritis may also be associated with high serum immunoreactive gastrin levels (Rooney et al., 1976) . This suggests a possible link between enteric hormones and anomalies in calcium metabolism occurring in rheumatoid arthritis. However, only 1 of the patients in the present study (patient 11, Table  5 ) had a raised serum immunoreactive gastrin level, though it is of interest that this patient had the highest serum ionised calcium concentration. In addition this patient had a raised serum calcitonin level, and it might be due to the fact that hypergastrinaemia can stimulate calcitonin secretion in man (Hennessy et al., 1973) . Serum glucagon levels were normal in all patients studied.
The role of vitamin D in calcium metabolism in patients with rheumatoid arthritis has not been thoroughly investigated. In a recent study of 5 patients with rheumatoid arthritis bone biopsy, showed osteomalacia and secondary hyperparathyroidism, and these findings were considered to be secondary to a dietary deficiency of vitamin D, assessed retrospectively by dietary histories (Maddison and Bacon, 1974 Rowe and Stamp, 1974) . A number of antirheumatic drugs are also known to be associated with liver microsomal enzyme induction in experimental animals (Conney, 1967) , but there was no evidence of this occurring in patients in the present study as judged by urinary D-glucaric acid levels.
The patients in Maddison and Bacon's study were selected because they had bone fractures and they tended to be older and more severely affected by the arthritis than the patients in this study. In addition it seems germane to note that in the radiological studies of skeletal status in very large numbers of patients with rheumatoid arthritis previouslyreported no circumstantial evidence of osteomalacia was found (Kennedy and Lindsay, 1977) . In addition, the absence of supportive biochemical evidence in a prior study (Kennedy et al., 1975) would seem to suggest that the incidence of hypovitaminosis D is probably confined to a very small select group of the rheumatoid population and indeed perhaps not to any greater extent than that in the general population.
Examination of the indices of articular bone damage showed significant correlation between the erosion score and the metacarpal index, tending to suggest that whatever is occurring at the joint surface is also being reflected at the midpoint of the shaft of the metacarpal. Thus, the metacarpal index would seem to provide a reasonably simple guide to the extent of bone damage occurring in the hand of a rheumatoid patient. There was also a good correlation between the erosion score (Dc) and the joint space narrowing score (JSNc), suggesting that the development ofbony defects parallels the development of cartilage destruction.
None of the patients in this study had any evidence of any alternative disease which could have explained the hypercalcaemia such as the milk-alkali syndrome, hypervitaminosis D, sarcoidosis, or malignancy. It is possible that the increased serum calcium concentrations might be due simply to erosion of bone, in which case it might be anticipated that they would correlate with activity of joint disease as judged by clinical, laboratory, and radiological parameters. There was no such correlation between hypercalcaemia and disease activity based on the patient's pain index, articular index of joint tenderness, functional grade, haemoglobin concentration, erythrocyte sedimentation rate, and serum protein concentration, nor with the radiological indices of bone damage. However, this does not totally exclude the possibility of any influence of disease activity on the production of hypercalcaemia, since the number of patients studied was small and the disease relatively long standing. Nevertheless, the fact that the hypercalcaemia is apparently not a constant feature for any one patient could be consistent with variation in the rate of bone destruction, which is not an unlikely possibility in a disease with such clinical variation.
Another variable which might explain the elevated serum ionised calcium levels is administration of antirheumatic drugs. None of the patients had taken any medication within 12 hours of the study, but persistence of drug effect cannot be discounted. Also it is possible that non-steroidal anti-inflammatory drugs or corticosteroids may interfere with plasma binding of calcium, thus producing abnormalities in serum ionised calcium measurements. Against, this however, is the fact that all the patients in this study had had no drug therapy for a minimum of 12 hours before its start, and additionally there is no reported evidence that these drugs do produce interference in this way.
It might be argued that cessation of therapy in itself could cause a release of calcium from its binding sites on albumin. However, it is of interest that the patients with rheumatoid arthritis studied in South Africa (Meyers et al., 1976) had approximately the same incidence (30 %) of increased serum ionised calcium levels and all were currently receiving nonsteroidal anti-inflammatory drugs. Northover (1973) , using amounts of indomethacin in excess of normal therapeutic doses, has shown in vitro that the drug will reduce calcium binding to the membranes of endothelial cells, but the relevance of this single observation to the present clinical studies is not apparent. Careful search of the literature has failed to find any other publication on the effects of nonsteroidal anti-inflammatory drugs on serum ionised calcium determinations.
If hyperparathyroidism is not the cause of the increased serum ionised calcium concentrations and the other biochemical abnormalities observed, the question arises of what they may be due to. The situation in rheumatoid arthritis has some resemblance to that pertaining to increased serum ionised calcium concentrations in neoplasm, where in the presence of biochemical evidence strongly suggestive of hyperparathyroidism immunoassay of PTH may be normal (Heath, 1976; Woodhead and Walker, 1976) . Conceivably in rheumatoid arthritis and in certain neoplasms polypeptides may be produced which have PTH-like activity but cannot yet be measured by the current immunoassay procedures. An alternative explanation is that the hypercalcaemia may be the result of effects of prostaglandin E2. Prostaglandin levels are increased in the synovial fluid in rheumatoid arthritis (Higgs et al., 1974), and Robinson et al. (1975) have shown in bone culture studies in vitro that all the bone-resorption-stimulating activity in rheumatoid synovial fluid can be accounted for by prostaglandin E2. Krane (1974) also demonstrated bone resorbing factor from synovial cell culture media but did not consider this to be due to prostaglandin E2. To date no measurement has been made of prostaglandin E2 in the sera of patients with rheumatoid arthritis, but conceivably this, if it were raised, could cause bone resorption and hypercalcaemia. It is not known whether prostaglandin E2 could account for the other biochemical abnormalities of mineral metabolism observed in the present study, and clearly this is worthy of further study. It is interesting to note that sera from patients with rheumatoid arthritis have been shown to cause resorption of bone in tissue culture and that this effect was most marked in serum with high calcium concentrations .
Another substance with PTH-like action is osteoclast-activating factor, OAF (Horton et al., 1972) , a substance which has been isolated from lymphocytes. The effects of OAF on bone in vitro resemble those of PTH (Raisz et al., 1975) , but effects of injection of equipotent in vitro doses of the 2 substances in vivo in rats differ in that PTH affects serum calcium and phosphate while OAF does not, suggesting that OAF is a local rather than a systemic bone resorbing factor. This would also seem an obvious area for further investigation. Biochemical effects particularly regarding renal handling of calcium and phosphate have, like PGE2, not been studied with OAF, and clearly require further investigation.
In conclusion, the results of the present study indicate that hypercalcaemia is a not uncommon feature of rheumatoid arthritis. The hypercalcaemia is associated with biochemical abnormalities suggestive of hyperparathyroidism, but serum concentrations of immunoreactive parathyroid hormone are normal. Since sera of patients with rheumatoid arthritis, especially those with hypercalcaemia, cause bone resorption in vitro there seems little doubt that bone loss in rheumatoid arthritis is an active process. Finally, the fact that calcitonin and hydrocortisone block the resorptive effect of rheumatoid sera on bone in vitro (Kennedy and Lindsay, 1977) may have therapeutic possibilities.
